Implementation of Therapy Together

NCT06040619 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-09-11

No results posted yet for this study

Summary

The goal of this clinical trial is to learn about the implementation of Therapy Together, a pediatric constraint-induced movement therapy program in young children with unilateral cerebral palsy. The main question\[s\] it aims to answer are:

* Is the Therapy Together program effective in improving hand function and occupational performance compared to usual care?
* Is it feasible to implement the Therapy Together program within the standard care, early intervention framework?

Participants will participate in an 8-week pediatric constraint-induced movement therapy program. Researchers will compare the group completing the Therapy Together Program to a group that is receiving usual care to see if there is a difference in the change in hand function, occupational performance, and development.

Conditions

  • Cerebral Palsy
  • Hemiplegic Cerebral Palsy

Interventions

BEHAVIORAL

Therapy Together

8-week caregiver-led pediatric constraint-induced movement therapy program

BEHAVIORAL

Usual Care

8 weeks of usual care received in an early intervention therapy program

Sponsors & Collaborators

  • American Occupational Therapy Foundation

    collaborator OTHER
  • Texas Scottish Rite Hospital for Children

    lead OTHER

Principal Investigators

  • Angela Shierk, PhD · Scottish Rite for Children

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
3 Months
Max Age
71 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-13
Primary Completion
2026-05-31
Completion
2026-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06040619 on ClinicalTrials.gov